Silence Therapeutics (SLN)
NASDAQ:SLN
Want to see SLN full AI Analyst Report?
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | £ 559.00K | £ 43.26M | £ 25.38M | £ 17.65M | £ 12.41M |
| Gross Profit | £ 344.00K | £ 31.45M | £ 15.06M | £ 6.68M | £ 4.96M |
| Operating Income | £ -89.75M | £ -63.32M | £ -49.60M | £ -49.76M | £ -45.81M |
| EBITDA | £ -88.05M | £ -48.99M | £ -49.78M | £ -39.94M | £ -45.42M |
| Net Income | £ -88.61M | £ -45.31M | £ -43.27M | £ -41.03M | £ -39.41M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | £ 85.11M | £ 117.73M | £ 68.79M | £ 71.14M | £ 73.54M |
| Total Assets | £ 131.44M | £ 161.92M | £ 119.45M | £ 107.50M | £ 96.19M |
| Total Debt | £ 160.00K | £ 93.49K | £ 346.00K | £ 446.00K | £ 137.00K |
| Net Debt | £ -11.12M | £ -96.86M | £ -68.44M | £ -54.37M | £ -73.40M |
| Total Liabilities | £ 69.14M | £ 54.83M | £ 97.45M | £ 85.43M | £ 87.67M |
| Stockholders' Equity | £ 62.30M | £ 107.10M | £ 21.99M | £ 22.07M | £ 8.53M |
| Cash Flow | |||||
| Free Cash Flow | £ -62.33M | £ -54.22M | £ -39.40M | £ -57.59M | £ 7.39M |
| Operating Cash Flow | £ -62.27M | £ -54.05M | £ -39.35M | £ -57.04M | £ 9.19M |
| Investing Cash Flow | £ -47.99M | £ -17.55M | £ 16.43M | £ -20.50M | £ 11.71M |
| Financing Cash Flow | £ 15.00K | £ 113.54M | £ 25.16M | £ 52.58M | £ 41.45M |